Transgene (0OCQ) Stock Statistics & Valuation Metrics

Transgene has a market cap or net worth of €79.44M. The enterprise value is €83.28M.

Transgene has 132,293,930 shares outstanding. The number of shares has decreased by -2.65% in one year.

Transgene’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Transgene is ―. Transgene’s PEG ratio is ―.

In the last 12 months, Transgene had revenue of 7.90M and earned -22.33M in profits. Earnings per share was -0.22.

In the last 12 months, operating cash flow was -43.65M and capital expenditures -3.90M, giving a free cash flow of -47.55M billion.

Transgene pays an annual dividend of ―, resulting in a dividend yield of ―

Transgene upcoming earnings date is Sep 16, 2025, TBA Not Confirmed.

Transgene as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Transgene has paid 0.00 in taxes.

Transgene EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Transgene has €15.32M in cash and marketable securities with €1.26M in debt, giving a net cash position of -€15.23M billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Transgene is ―, which is 11.43% higher than the current price. The consensus rating is ―